Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Cancer Therapy
Efficacy of antiemetic drugs evaluated
October 6th, 2005
The efficacy of antiemetic drugs was evaluated in patients receiving chemotherapy. "The tendency of chemotherapeutic regimens to cause vomiting is dependent on the individual drugs in the regimen. The authors analyzed data combined from 2 phase III trials to assess the effect of the neurokinin-1 (NK1) antagonist aprepitant combined with a 5HT(3) antagonist plus a corticosteroid in a subpopulation receiving >1 emetogenic chemotherapeutic agent," scientists in the United States reported. "In the current study, 1043 cisplatin-naive patients (42% were women) receiving cisplatin-based ({{>=}}70 mg/m2) chemotherapy were assigned randomly...
Source: Women's Health Weekly (2005-10-06)
|
